Growing evidence of the safety of JAK inhibitors in patients with rheumatoid arthritis

por Harigai, Masayoshi
Publicado 2019

Targeting Low Disease Activity in Elderly-Onset Rheumatoid Arthritis: Current and Future Roles of Biological Disease-Modifying Antirheumatic Drugs

por Sugihara, Takahiko, Harigai, Masayoshi
Publicado 2016

Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache?

por Harigai, Masayoshi, Honda, Suguru
Publicado 2020

MPO-ANCA positive interstitial pneumonia: Current knowledge and future perspectives

por Bando, Masashi, Homma, Sakae, Harigai, Masayoshi
Publicado 2021

Molecular targeted therapies for microscopic polyangiitis and granulomatosis with polyangiitis

por Harigai, Masayoshi, Tsutsumino, Michi, Takada, Hideto, Nagasaka, Kenji
Publicado 2019

Unincreased risk of hospitalized infection under targeted therapies versus methotrexate in elderly patients with rheumatoid arthritis: a retrospective cohort study

por Sakai, Ryoko, Tanaka, Eiichi, Majima, Masako, Harigai, Masayoshi
Publicado 2022

Advances in Takayasu arteritis: An Asia Pacific perspective

por Danda, Debashish, Manikuppam, Prathyusha, Tian, Xinping, Harigai, Masayoshi
Publicado 2022

Development of a scoring model for the Sharp/van der Heijde score using convolutional neural networks and its clinical application

por Honda, Suguru, Yano, Koichiro, Tanaka, Eiichi, Ikari, Katsunori, Harigai, Masayoshi
Publicado 2022

Management of End-stage Renal Disease Associated with Systemic Rheumatic Diseases

por Honda, Suguru, Katsumata, Yasuhiro, Karasawa, Kazunori, Yamanaka, Hisashi, Harigai, Masayoshi
Publicado 2019

A multicenter, open-label, efficacy, pharmacokinetic, and safety study of adalimumab in Japanese patients with ankylosing spondylitis

por Kobayashi, Shigeto, Harigai, Masayoshi, Mozaffarian, Neelufar, Pangan, Aileen L., Sharma, Shringi, Brown, L. Steven, Miyasaka, Nobuyuki
Publicado 2011

Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study

por Nakayama, Masanori, Furuya, Takefumi, Inoue, Eisuke, Tanaka, Eiichi, Ikari, Katsunori, Taniguchi, Atsuo, Yamanaka, Hisahi, Harigai, Masayoshi
Publicado 2020

Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report

por Kishi, Takayuki, Tani, Yumi, Okiyama, Naoko, Mizuochi, Kiyoshi, Ichimura, Yuki, Harigai, Masayoshi, Nagata, Satoru, Miyamae, Takako
Publicado 2021

Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model

por Higuchi, Tomoaki, Takagi, Kae, Tochimoto, Akiko, Ichimura, Yuki, Hirose, Hikaru, Sawada, Tatsuo, Shibata, Noriyuki, Harigai, Masayoshi, Kawaguchi, Yasushi
Publicado 2023

Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis

por Fukuda, Shin, Kohsaka, Hitoshi, Takayasu, Aiko, Yokoyama, Waka, Miyabe, Chie, Miyabe, Yoshishige, Harigai, Masayoshi, Miyasaka, Nobuyuki, Nanki, Toshihiro
Publicado 2014

Diagnostic performance of measuring antibodies to the glycopeptidolipid core antigen specific to Mycobacterium avium complex in patients with rheumatoid arthritis: results from a c...

por Hirose, Wataru, Uchiyama, Takashi, Nemoto, Asuka, Harigai, Masayoshi, Itoh, Kenji, Ishizuka, Toshiaki, Matsumoto, Mitsuyo, Yamaoka, Kazue, Nanki, Toshihiro
Publicado 2015

Sirukumab in rheumatoid arthritis refractory to sulfasalazine or methotrexate: a randomized phase 3 safety and efficacy study in Japanese patients

por Takeuchi, Tsutomu, Yamanaka, Hisashi, Harigai, Masayoshi, Tamamura, Ryo, Kato, Yuichi, Ukyo, Yoshifumi, Nakano, Toshikazu, Hsu, Benjamin, Tanaka, Yoshiya
Publicado 2018

The Safety Profile of Upadacitinib in Patients with Rheumatoid Arthritis in Japan

por Yamaoka, Kunihiro, Tanaka, Yoshiya, Kameda, Hideto, Khan, Nasser, Sasaki, Nobuhito, Harigai, Masayoshi, Song, Yanna, Zhang, Ying, Takeuchi, Tsutomu
Publicado 2021

Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis

por Koike, Ryuji, Harigai, Masayoshi, Atsumi, Tatsuya, Amano, Koichi, Kawai, Shinichi, Saito, Kazuyoshi, Saito, Tomoyuki, Yamamura, Masahiro, Matsubara, Tsukasa, Miyasaka, Nobuyuki
Publicado 2009

Diagnostic reliability of magnetic resonance imaging for central nervous system syndromes in systemic lupus erythematosus: a prospective cohort study

por Katsumata, Yasuhiro, Harigai, Masayoshi, Kawaguchi, Yasushi, Fukasawa, Chikako, Soejima, Makoto, Kanno, Tokiko, Nishimura, Katsuji, Yamada, Takayuki, Yamanaka, Hisashi, Hara, Masako
Publicado 2010

Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients

por Koike, Takao, Harigai, Masayoshi, Inokuma, Shigeko, Ishiguro, Naoki, Ryu, Junnosuke, Takeuchi, Tsutomu, Takei, Syuji, Tanaka, Yoshiya, Ito, Kyoko, Yamanaka, Hisashi
Publicado 2011